Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Instadose Pharma Corp (OP:INSD)

0.0001 -0.0010 (-90.91%)
Streaming Delayed Price Updated: 11:01 AM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Instadose Pharma Corp

< Previous 1 2 Next >
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (INSD)
From Law Offices of Howard G. Smith
Via Business Wire
Investor Action Notice: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (INSD) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Shareholder Action Notice: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (INSD) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Shareholder Action Alert: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
The Law Offices of Frank R. Cruz Announces Investigation of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (INSD) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (INSD) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Investor Action Reminder: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (INSD) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Instadose Pharma Touts Having Completed Largest International Cannabis Delivery: Over 2 Metric Tons
Instadose Pharma Corp (OTCPK: INSD) reported Wednesday that it recently delivered a record-breaking shipmen... 
Via Benzinga
Shareholder Action Notice: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Instadose Pharma Corp. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
OTC:INSD Shareholder Notice: Investigation over Possible Securities Laws Violations by Instadose Pharma Corp.
San Diego, CA -- (SBWIRE) -- 12/17/2021 -- An investigation was announced concerning potential securities laws violations by Instadose Pharma Corp. in connection with certain financial statements. 
Via SBWire
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Instadose Pharma Corp. and Encourages Investors with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit Regulatory Compliance
Instadose (INSD) Responds to SEC Suspension of Trading on OTC Markets
CHESAPEAKE, VA / ACCESSWIRE / November 24, 2021 / Instadose Pharma Corp. (OTC PINK:INSD) today announced that on November 23, 2021, the Company was notified by the SEC that it had ORDERED, pursuant to... 
From Instadose Pharma Corp.
Via AccessWire
Topics Regulatory Compliance
Instadose Secures Another African JV Partner
Instadose Pharma Corp. Announces that Instadose Canada has Established a Strategic Joint Venture Partnership in Cameroon Strengthening its Global Distribution Platform CHESAPEAKE, VA / ACCESSWIRE /... 
From Instadose Pharma Corp.
Via AccessWire
Topics Cannabis Economy
Milestone for Instadose
Instadose Announces Import Permit for 2,125 kg of Medical Cannabis to North Macedonia CHESAPEAKE, VA / ACCESSWIRE / November 9, 2021 / Instadose Pharma Corp. (formerly Mikrocoze, Inc.)... 
From Instadose Pharma Corp.
Via AccessWire
Topics Cannabis
Instadose Announces Strategic JV Partner in India
Instadose Pharma Announces Instadose Canada has Established a Strategic Joint Venture Partner in India Strengthening its Global Distribution Platform CHESAPEAKE, VA / ACCESSWIRE / November 4, 2021 /... 
From Instadose Pharma Corp.
Via AccessWire
Topics Cannabis
InstadosePharma Announces Columbia JV and Supply Agreement
CHESAPEAKE, VA 
From Instadose Pharma Corp.
Via AccessWire
Topics Cannabis Derivatives Supply Chain
Instadose Pharma Corp and the Future of Medicinal Cannabis
Instadose Pharma Corp speaks to the potential impact of the growing global market for Medicinal Cannabis and the benefits for the developing world. CHESAPEAK, VA / ACCESSWIRE / October 28, 2021 /... 
From Instadose Pharma Corp.
Via AccessWire
Topics Cannabis Climate Change
Instadose Pharma Announces that Instadose Canada Has Established a Strategic Import Location in Portugal for its Global Distribution Platform
CHESAPEAKE, VA / ACCESSWIRE / October 27, 2021 / Instadose Pharma Corp. (formerly Mikrocoze) is proud to announce that Instadose Pharma Corp (Canada) ("Instadose Canada", "Instadose" or the "Company"),... 
From Instadose Pharma Corp.
Via AccessWire
Topics Cannabis
Instadose Pharma Corp - Establishes New Supply Route
Instadose Pharma Corp Canada successfully delivers 176.5 KG of high grade medicinal Cannabis from South Africa to North Macedonia CHESAPEAKE, VA / ACCESSWIRE / October 25, 2021 / Instadose Pharma Corp.... 
From Instadose Pharma Corp.
Via AccessWire
Topics Cannabis Law Enforcement
Instadose Pharma Corp. Announces Update to Arrangement!
CHESAPEAKE, VA / ACCESSWIRE / October 21, 2021 / Instadose Pharma Corp. (OTC Pink:INSD) ("the "Company"), a shell company, today announced that Instadose Pharma Corp., an organization incorporated... 
From Instadose Pharma Corp.
Via AccessWire
Topics Law Enforcement
Instadose Pharma Corp. Announces Vote
Instadose Pharma Corp. Announces Results of Annual and Special Meeting Including the Election of its Board of Directors and Approval of the Arrangement with Instadose Pharma Corp. (formerly... 
From Instadose Pharma Corp.
Via AccessWire
Topics Cannabis Derivatives Retirement
Instadose Pharma Corp Merger
CHESAPEAKE, VA / ACCESSWIRE / September 24, 2021 / Instadose Pharma Corp. ("the "Company"), a shell company, today announced that it has entered into a plan of arrangement to acquire all the issued and... 
From Instadose Pharma Corp.
Via AccessWire
Topics Cannabis Law Enforcement
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.